CS logo
small CS logo
University of Rochester Investigational Drug Pharmacy

Rochester, New York, United States

About University of Rochester Investigational Drug Pharmacy


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at University of Rochester Investigational Drug Pharmacy


During the past decade, University of Rochester Investigational Drug Pharmacy conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "University of Rochester Investigational Drug Pharmacy" #1 collaborator was "Academic GI Cancer Consortium (AGICC)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

Clinical Trials Conditions at University of Rochester Investigational Drug Pharmacy


According to Clinical.Site data, the most researched conditions in "University of Rochester Investigational Drug Pharmacy" are "Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive" (1 trials) and "Metastatic Cancer Pancreas" (1 trials). Many other conditions were trialed in "University of Rochester Investigational Drug Pharmacy" in a lesser frequency.

Clinical Trials Intervention Types at University of Rochester Investigational Drug Pharmacy


Most popular intervention types in "University of Rochester Investigational Drug Pharmacy" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Bosutinib" (1 trials), "Gemcitabine" (1 trials), "Imatinib" (1 trials), "Nab-paclitaxel" (1 trials) and "PF-03084014" (1 trials). Other intervention names were less common.

Clinical Trials Genders at University of Rochester Investigational Drug Pharmacy


The vast majority of trials in "University of Rochester Investigational Drug Pharmacy" are 2 trials for "All" genders.

Clinical Trials Status at University of Rochester Investigational Drug Pharmacy


Currently, there are NaN active trials in "University of Rochester Investigational Drug Pharmacy". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in University of Rochester Investigational Drug Pharmacy, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in University of Rochester Investigational Drug Pharmacy, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".